Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, Revision: v3.6.5, was added to the study's record history, replacing Revision: v3.6.4. This indicates a software/interface update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew revision label v3.6.4 was added to the study record history, replacing the previous v3.6.3. This indicates a minor update to the page history rather than a change to the study data or content.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.6.3 was added to the study record history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study record title was updated to use the uHCC abbreviation and corrected wording, and the recruitment status was changed to Active, not recruiting; additional sections such as Contacts/Locations, Eligibility, Outcome Measures, and Arms and Interventions were added.SummaryDifference2%

- Check65 days agoChange DetectedThe Record History page now includes links to 'Check who can join' and 'Find Contact Information' and shows the revision label updated to v3.6.0 from v3.5.5.SummaryDifference0.5%

- Check72 days agoChange DetectedThe page now shows the latest site revision as v3.5.5, replacing v3.5.4. This indicates a platform update that does not change the trial data.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.